ISHLT Acellular Ex Vivo Lung Perfusion (EVLP) Research Grant
Funds research to advance acellular Ex Vivo Lung Perfusion (EVLP) technology, including optimization, repair, immunomodulation, and outcomes in lung transplantation.
Funder: International Society for Heart and Lung Transplantation
Due Dates: September 30, 2026: Full application submission deadline | September 30, 2026: ISHLT membership application deadline
Funding Amounts: One grant of up to $37,500 USD for a one-year project.
Summary: Supports research advancing acellular Ex Vivo Lung Perfusion (EVLP) technology, including optimization, repair, immunomodulation, and outcomes in lung transplantation.
Key Information: Applicant must be an ISHLT member or have applied for membership by the deadline.
Description
This grant supports research focused on furthering acellular Ex Vivo Lung Perfusion (EVLP) technology. Funded projects may address the optimization of perfusion techniques, the development of intervention and repair strategies, immunomodulation and reconditioning approaches, or outcomes research related to EVLP. The goal is to enhance the effectiveness and understanding of acellular EVLP in lung transplantation and related therapies.
